Eric M Dube Insider Trading $RTRX Travere Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eric M Dube.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eric M Dube. Eric M Dube is Chief Executive Officer in Retrophin, Inc. ($RTRX).
Eric M Dube in Travere Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eric M Dube: Chief Executive Officer
Holdings: 161,626 shares
Current Value: $3,243,834
Latest Transaction: Feb 09 2021
$RTRX Market Capitalization: $766.34M
$RTRX Previous Close: $20.07
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Eric M Dube in Travere Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 31.58 | 4,813 | 151,995 | 156,813 | 161.6 K to 156.8 K (-2.98 %) |
| Feb 09 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 31.41 | 4,813 | 151,176 | 161,626 | 166.4 K to 161.6 K (-2.89 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 17,500 | 0 | 166,439 | 148.9 K to 166.4 K (+11.75 %) |
| Feb 05 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 17,500 | 0 | 166,439 | 148.9 K to 166.4 K (+11.75 %) |
| Feb 03 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 28.91 | 2,406 | 69,557 | 148,939 | 151.3 K to 148.9 K (-1.59 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 30.75 | 2,406 | 73,985 | 151,345 | 153.8 K to 151.3 K (-1.56 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 29.60 | 6,328 | 187,282 | 153,751 | 160.1 K to 153.8 K (-3.95 %) |
| Feb 02 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 15,000 | 0 | 160,079 | 145.1 K to 160.1 K (+10.34 %) |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 26.88 | 212,600 | 5,714,688 | 212,600 | |
| Jan 25 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 57,260 | 0 | 145,079 | 87.8 K to 145.1 K (+65.20 %) |
| Jan 07 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 27.01 | 3,438 | 92,860 | 87,819 | 91.3 K to 87.8 K (-3.77 %) |
| Jan 07 2021 | RTRX | Travere Therapeuti ... | Dube Eric M | Chief Executive Off ... | Sell | S | 26.65 | 3,438 | 91,623 | 91,257 | 94.7 K to 91.3 K (-3.63 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 19.29 | 1,565 | 30,186 | 94,695 | 96.3 K to 94.7 K (-1.63 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 19.28 | 9,240 | 178,133 | 96,260 | 105.5 K to 96.3 K (-8.76 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 3,000 | 0 | 105,500 | 102.5 K to 105.5 K (+2.93 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 102,500 | 77.5 K to 102.5 K (+32.26 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 19.29 | 1,565 | 30,186 | 94,695 | 96.3 K to 94.7 K (-1.63 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 19.28 | 9,240 | 178,133 | 96,260 | 105.5 K to 96.3 K (-8.76 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 3,000 | 0 | 105,500 | 102.5 K to 105.5 K (+2.93 %) |
| Sep 22 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 102,500 | 77.5 K to 102.5 K (+32.26 %) |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 35,000 | 0 | 35,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 15.46 | 300,000 | 4,638,000 | 300,000 | |
| Jan 31 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 35,000 | 0 | 77,500 | 42.5 K to 77.5 K (+82.35 %) |
| Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 15.14 | 3,750 | 56,775 | 42,500 | 46.3 K to 42.5 K (-8.11 %) |
| Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 13.94 | 3,750 | 52,275 | 46,250 | 50 K to 46.3 K (-7.50 %) |
| Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 15.14 | 3,750 | 56,775 | 42,500 | 46.3 K to 42.5 K (-8.11 %) |
| Jan 08 2020 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Sell | S | 13.94 | 3,750 | 52,275 | 46,250 | 50 K to 46.3 K (-7.50 %) |
| May 10 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| May 10 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 6,000 | 0 | 6,000 | |
| Jan 08 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
| Jan 08 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Option Exercise | A | 23.34 | 400,000 | 9,336,000 | 400,000 | |
| Jan 08 2019 | RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Off ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Page: 1